News

Paediatricians work in incredibly challenging times. But, say Camilla, the College's VP for Education & Professional Development and Hannah, Chair of Trainees Committee, this specialty is rewarding like no other, and there's much more we can all do.

The Prime Minister has today called for urgent action to boost the number of children and young people receiving life-saving vaccinations. This comes as it is revealed that the UK has lost its "measles-free" status with the WHO, three years after it had eliminated the virus.

We believe that child health research should be embedded as part of every paediatrician’s training, and throughout their careers. If you’re a consultant, SAS doctor or CCT holder, we invite you to complete our 2019 Participation in Child Health Research survey and tell us how we can support you in c...

RCPCH's immunisation expert Dr David Elliman says "compulsion may work in some countries, but it is not for us".

Boys aged 12-13 in Northern Ireland are to be offered a vaccine to protect them against Human Papillomavirus (HPV) related cancers, the Department of Health has announced. RCPCH responds.

Developing new skills, meeting new people, networking with like-minded colleagues, carrying out a sense of purpose... The benefits often outweigh the time given, which may be why more than 1,100 of you volunteer for the College. Whether it's representing your region or specialty on a committee, work...

The RCPCH highly recommends vaccination and that anyone who has concerns or questions talk to their health visitor, practice nurse or general practitioner (GP).

In a guest blog anticipating the start of 'flu season, RCPCH immunisation experts, Professor Helen Bedford and Dr David Elliman share their thoughts on improving rates of vaccination among children, some misconceptions around the flu vaccination and the role of the paediatrician.

RCPCH President Professor Russell Viner reiterates the importance of reflective practice as "crucial for doctors".

Professor Helen Bedford stresses the importance of the Measles, Mumps and Rubella (MMR) vaccine in response to news that measles rates in Europe have hit a record high in this decade.